---
title: "Syntec Optics prices $20M stock offering at $7 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284504645.md"
description: "Syntec Optics (OPTX) has announced a public offering of 2.86 million shares of common stock priced at $7.00 per share, aiming for gross proceeds of $20 million. The offering includes a 30-day option for the underwriter to buy an additional 428,571 shares, which could increase total proceeds. The net proceeds will be utilized for unspecified purposes."
datetime: "2026-04-29T06:21:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284504645.md)
  - [en](https://longbridge.com/en/news/284504645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284504645.md)
---

# Syntec Optics prices $20M stock offering at $7 per share

Syntec Optics (OPTX) said it has priced an underwritten public offering of 2.86M shares of common stock at $7.00 per share. The gross proceeds are expected to be $20M. The offering includes a 30-day option for the underwriter to purchase up to 428,571 additional shares, potentially increasing total proceeds. The net proceeds are expected to be used...

### Related Stocks

- [OPTX.US](https://longbridge.com/en/quote/OPTX.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [OPTXW.US](https://longbridge.com/en/quote/OPTXW.US.md)

## Related News & Research

- [Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock | OPTX Stock News](https://longbridge.com/en/news/284467925.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Stryker Buys Amplitude Vascular Systems For Upto $835 Mln To Expand Vascular Treatment Business](https://longbridge.com/en/news/286889480.md)
- [Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal](https://longbridge.com/en/news/286808399.md)
- [Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results](https://longbridge.com/en/news/286942821.md)